SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Baird Initiates Coverage On Albireo Pharma with Outperform Rating, Announces Price Target of $52

Baird analyst Brian Skorney initiates coverage on Albireo Pharma (NASDAQ:ALBO) with a Outperform rating and announces Price Target of $52.

Benzinga · -
Baird analyst Brian Skorney initiates coverage on Albireo Pharma (NASDAQ: ALBO) with a Outperform rating and announces Price Target of $52.